CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-19 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | Sale | −9,534 | $15.28 | $146K | 52,177 |
| 2024-08-19 | DAVIS STEPHEN CEO | Sale | −31,747 | $15.28 | $485K | 186,555 |
| 2024-08-16 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Grant or award | +5,275 | 39,839 | ||
| 2024-08-16 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Grant or award | +13,629 | 53,468 | ||
| 2024-08-16 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | Grant or award | +5,024 | 48,082 | ||
| 2024-08-16 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | Grant or award | +13,629 | 61,711 | ||
| 2024-08-16 | DAVIS STEPHEN CEO | Grant or award | +17,333 | 173,520 | ||
| 2024-08-16 | DAVIS STEPHEN CEO | Grant or award | +44,782 | 218,302 | ||
| 2024-08-12 | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | Grant or award · Stock Option (Right to Buy) | +324,582 | 324,582 | ||
| 2024-08-12 | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | Grant or award · Restricted Stock Units | +64,544 | 64,544 | ||
| 2024-06-10 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Sale | −975 | $14.79 | $14K | 34,564 |
| 2024-06-08 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise | +1,893 | 35,539 | ||
| 2024-06-08 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −1,893 | 0 | ||
| 2024-05-29 | Ndu Adora Director | Option exercise | +6,652 | 11,033 | ||
| 2024-05-29 | Ndu Adora Director | Option exercise · Restricted Stock Units | −6,652 | 0 | ||
| 2024-05-29 | Ndu Adora Director | Grant or award · Director Stock Options (Right to Buy) | +15,959 | 15,959 | ||
| 2024-05-29 | Ndu Adora Director | Grant or award · Restricted Stock Units | +9,387 | 9,387 | ||
| 2024-05-29 | GAROFALO ELIZABETH A. Director | Option exercise | +6,652 | 22,514 | ||
| 2024-05-29 | GAROFALO ELIZABETH A. Director | Option exercise · Restricted Stock Units | −6,652 | 0 | ||
| 2024-05-29 | GAROFALO ELIZABETH A. Director | Grant or award · Director Stock Options (Right to Buy) | +15,959 | 15,959 |
Page 11 of 63 · 1,260 trades